Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ned Tijdschr Geneeskd ; 149(28): 1568-72, 2005 Jul 09.
Artigo em Holandês | MEDLINE | ID: mdl-16038160

RESUMO

The 1997 practice guideline from the Dutch College of General Practitioners concerning lower urinary-tract symptoms (LUTS) in middle-aged and elderly men has been revised and some points have been adapted. The underlying cause of LUTS in middle-aged and elderly men is an improperly functioning voiding mechanism of the bladder associated with ageing. Symptoms are not simply due to prostate enlargement. In uncomplicated LUTS the patient's perception of the level of inconvenience is very important in considering and choosing therapeutic options. Percussion of the bladder after micturition is no longer universally advised. In general, invasive treatment is more effective in relieving symptoms than medical treatment, although invasive treatment causes more adverse effects. LUTS and prostate cancer are different entities, and LUTS is not a risk factor for prostate cancer. The issue of prostate cancer is discussed in this practice guideline in order to clear up popular misconceptions and to enhance the practical implementation of this guideline.


Assuntos
Envelhecimento/fisiologia , Medicina de Família e Comunidade/normas , Padrões de Prática Médica/normas , Transtornos Urinários/terapia , Idoso , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Próstata/fisiologia , Neoplasias da Próstata/epidemiologia , Sociedades Médicas , Transtornos Urinários/etiologia , Transtornos Urinários/cirurgia
2.
Ned Tijdschr Geneeskd ; 149(10): 523-7, 2005 Mar 05.
Artigo em Holandês | MEDLINE | ID: mdl-15782687

RESUMO

In the revised practice guideline for the diagnosis and treatment of patients with a depressive disorder in general practice the distinction between mild and severe depression has been removed. By paying attention to a number of risk factors, the general practitioner can detect patients with a hidden depressive disorder. The general practitioner's strategy is aimed at reducing symptoms and restoring the ability to function normally. Factors that define the strategy are in particular patient's degree of suffering and dysfunctioning, and the patient's preferences and demands. In primary care tricyclic antidepressants and specific serotonin re-uptake inhibitors are the drugs of first choice: both are equally effective; the nature of the side effects differs.


Assuntos
Antidepressivos/uso terapêutico , Transtorno Depressivo/diagnóstico , Medicina de Família e Comunidade/normas , Padrões de Prática Médica/normas , Antidepressivos/efeitos adversos , Terapia Cognitivo-Comportamental , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/terapia , Humanos , Países Baixos , Fatores de Risco , Sociedades Médicas
4.
Ned Tijdschr Geneeskd ; 146(7): 309-13, 2002 Feb 16.
Artigo em Holandês | MEDLINE | ID: mdl-11876034

RESUMO

The typical form of acute gout can be clinically diagnosed. The term 'complicated gout' is used if there are more than three acute attacks of gout per year, tophi or urate stones in the urinary tracts. In the case of recurrent probable acute gout, a diagnostic fine needle aspirate from the joint during an attack is indicated. First choice treatment of acute gout consists of NSAIDs. Colchicine is the second choice treatment and the third choice treatment consists of corticosteroids. Excessive alcohol use should be limited. Treatment of chronic gout depends on the uric acid excretion in the 24-hour urine. If the level of excretion is too low, the first choice should be benzbromarone, and if the uric acid output is too high, allopurinol should be the treatment of first choice. Increased fluid intake is recommended; maintenance treatment with colchicine is not advised. Consultation with or referral to a rheumatologist is indicated in the case of doubt about the diagnosis of 'acute gout' or 'complicated gout', or (suspected) bacterial arthritis and insufficient treatment effect.


Assuntos
Supressores da Gota/uso terapêutico , Gota/diagnóstico , Gota/tratamento farmacológico , Guias de Prática Clínica como Assunto/normas , Doença Aguda , Corticosteroides/uso terapêutico , Alopurinol/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Benzobromarona/uso terapêutico , Doença Crônica , Colchicina/uso terapêutico , Gota/complicações , Humanos , Países Baixos , Recidiva , Uricosúricos/uso terapêutico
5.
Ned Tijdschr Geneeskd ; 143(31): 1611-4, 1999 Jul 31.
Artigo em Holandês | MEDLINE | ID: mdl-10488373

RESUMO

The Dutch College of General Practitioners issued a standard 'Osteoporosis' with guidelines for prevention, diagnosis and treatment in patients who have a (probably) osteoporotic fracture, who are taking at least 7.5 mg corticosteroids per day for at least six months or who have questions about osteoporosis. The core of the management is information about lifestyle (stimulation of physical activity) and nutrition. Prevention of falling is to be stimulated; sedatives, excessive drinking and smoking are to be discouraged. Persons who cannot achieve a calcium intake of 500 mg/day, patients with osteoporotic fractures and takers of biphosphonates or corticosteroids whose calcium intake is insufficient are eligible for calcium suppletion. In patients with (probably) osteoporotic fractures and those taking 7.5 mg corticosteroids per day for longer than six months preventive treatment may be considered with alendronic acid for a maximum of 3 years, if several vertebral fractures are visible roentgenologically, the T score is < -2.5 (if age < 70 years) or the Z score < -1.0 (> 70 years).


Assuntos
Fraturas Ósseas/prevenção & controle , Osteoporose , Feminino , Humanos , Masculino , Osteoporose/diagnóstico , Osteoporose/prevenção & controle , Osteoporose/terapia , Educação de Pacientes como Assunto , Medição de Risco
6.
Ned Tijdschr Geneeskd ; 142(47): 2563-8, 1998 Nov 21.
Artigo em Holandês | MEDLINE | ID: mdl-10028352

RESUMO

Both the Netherlands College of Urologists (NVU) and the Dutch General Practice College (NHG) in recent years published guidelines for the management of benign hypertrophy of the prostate (BPH). The two differ in a number of respects and are not always consistent. The differences between the GP's and urologists' guidelines are mostly to be attributed to the difference in the patient populations visiting the GP and the urologist, respectively. In order to arrive a better adjustment concerning BPH patients between general practice and specialists, a team composed of NVU and NHG has drawn up 'Recommendations for transmural care'. These recommendations concern four subjects: diagnosis of micturition abnormalities, indication for examination of cancer of the prostate, drug treatment, indications for referring and re-referring of patients with micturition problems.


Assuntos
Hiperplasia Prostática/diagnóstico , Hiperplasia Prostática/terapia , Encaminhamento e Consulta/normas , Idoso , Idoso de 80 Anos ou mais , Medicina de Família e Comunidade/normas , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Hiperplasia Prostática/complicações , Neoplasias da Próstata/complicações , Neoplasias da Próstata/diagnóstico , Neoplasias da Próstata/terapia , Transtornos Urinários/etiologia , Urologia/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...